Home›Legal›BPC-157 in California
BPC-157 in California: Legal Status & Provider Guide (2026)
Quick Answer
BPC-157 is a prescription substance in the United States. BPC-157 has no FDA-approved drug application. It is classified as a research peptide and cannot be compounded by 503A/503B pharmacies under current federal guidance. Clinical use in the U.S. occurs in a legal gray area — consult a healthcare attorney and licensed prescriber for current federal standing. In California, compounding is governed by the California State Board of Pharmacy (CSBP). California allows nurse practitioners and physician assistants with standardized procedures or physician collaboration to prescribe compounded peptides. California's telehealth laws (AB 2019 and subsequent legislation) require an established patient-provider relationship before prescribing. Out-of-state prescribers cannot prescribe to California patients without a California license.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on any FDA bulk substances list for compounding.
Compounding Pharmacy Rules (Federal)
BPC-157 is not on the FDA 503A or 503B bulk substances lists, meaning licensed compounding pharmacies cannot legally compound it for individual patients under federal law. Its status as a bulk substance for compounding has been contested and remains legally uncertain. Some providers offer it under state-level regulatory frameworks, but federal compliance risk is elevated.
Also Known As
Body Protection Compound 157 · PL 14736
Primary Research Areas
- Tissue repair
- Gut health
- Tendon and ligament healing
- Angiogenesis
California Pharmacy Board & Compounding Rules
Compounding Overview
The California State Board of Pharmacy enforces strict compounding standards, often exceeding federal minimums. California has its own sterile compounding licensure category and requires all sterile compounding pharmacies to hold a specialty license. California pharmacies must comply with USP 797 (sterile) and USP 795 (non-sterile) standards. The California Medical Board also imposes strict telemedicine prescribing standards that affect peptide clinics operating as telehealth platforms serving California residents.
Notable Rules
- California requires a specialty sterile compounding license in addition to a standard pharmacy license.
- USP 797 and 795 compliance is mandatory for all California-licensed compounding pharmacies.
- The California Medical Board has specific guidance on prescribing practices for "off-label" and compounded medications.
- Out-of-state pharmacies must be licensed by CSBP to ship prescription compounds into California.
- California prohibits prescription dispensing without an established patient-provider relationship in most telehealth contexts.
Prescribing Requirements in California
California allows nurse practitioners and physician assistants with standardized procedures or physician collaboration to prescribe compounded peptides. California's telehealth laws (AB 2019 and subsequent legislation) require an established patient-provider relationship before prescribing. Out-of-state prescribers cannot prescribe to California patients without a California license.
About BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has been studied in animal models for tissue repair, gut protection, and angiogenesis. No completed Phase III human trials exist as of 2026.
For more research information, mechanism of action, and provider availability, see the BPC-157 research profile on PeptideBase.
Frequently Asked Questions
- Is BPC-157 legal in the United States?
- BPC-157 exists in a legal gray area. It is not FDA-approved and is not on the 503A/503B bulk compounding lists. Research-use possession is generally not a federal crime, but commercial sale and compounding for human use carry significant legal risk.
- Can a doctor prescribe BPC-157?
- A licensed prescriber may write an order for BPC-157, but compounding pharmacies subject to FDA oversight cannot legally compound it. Some providers operate under state regulations or as research programs. Patients should consult both a physician and legal counsel.
BPC-157 Providers in California
No providers currently listed in California for BPC-157. Browse the full directory to find providers offering BPC-157.
Browse all BPC-157 providers →BPC-157 Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare BPC-157 legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .